Veterinary Medicines

Biocan DHPPi+LR, Lyofilizát a rozpouštědlo pro injekční suspenzi

Authorised
  • Canine distemper virus, Live
  • Canine adenovirus 2, Live
  • Canine parvovirus, Live
  • Canine parainfluenza virus, Inactivated
  • Rabies virus, Inactivated
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
Download as PDF

Product identification

Medicine name:
Biocan DHPPi+LR, Lyofilizát a rozpouštědlo pro injekční suspenzi
Active substance:
  • Canine distemper virus, Live
  • Canine adenovirus 2, Live
  • Canine parvovirus, Live
  • Canine parainfluenza virus, Inactivated
  • Rabies virus, Inactivated
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, Live
    4.50
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine adenovirus 2, Live
    4.50
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine parvovirus, Live
    5.50
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine parainfluenza virus, Inactivated
    4.20
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Rabies virus, Inactivated
    2.00
    international unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
    32.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 97/016/04-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."